NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,040.00a day ago
1,058.10a day ago
arrow

LOWER/UPPER CIRCUITS

830.40
1,245.40
arrow
Ttk Healthcare Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 7.03%, in the last year to ₹872.75 Cr. Its sector's average revenue growth for the last fiscal year was 18.97%.
noteAnnual Net Profit,rose 29.94% in the last year to ₹81.66 Cr. Its sector's average net profit growth for the last fiscal year was 5.17%.
notePrice to Earning Ratio,is 22.26, lower than its sector PE ratio of 27.29.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 16.85%
Net profit growth 5Y CAGR : 20.85%
Ttk Healthcare Ltd Top mutual funds holding
arrow

About TTK Healthcare Limited

TTK Healthcare Limited is a public limited company incorporated on May 21, 1958, and is part of the TTK Group. The company is registered with its office at No.6, Cathedral Road, Chennai, and its equity shares are listed on BSE and NSE in India. It manufactures, markets, and distributes a broad portfolio covering five Strategic Business Units (SBUs): Pharmaceuticals (Animal Welfare), Consumer Products, Medical Devices, Foods, and Protective Devices (male contraceptives). The company operates 8 plants and 37 offices across India, serving all 28 states and 8 union territories, and exports to 54 countries, with exports accounting for 10.66% of its turnover. Key product brands include EVA cosmetics, Woodward’s Gripe Water, Good Home scrubbers and air fresheners, artificial heart valves, orthopedic implants, and male contraceptives.

 

TTK Healthcare Limited has no subsidiaries or joint ventures. The Board’s Report confirms the absence of subsidiary companies.

Key Milestones of TTK Healthcare Limited

  • Completed sale/transfer of the Human Pharma Division effective May 9, 2022.
  • Continued technology upgrades and automation across sales, finance, and production processes in the latest year.
  • Board approved the annual financial statements on May 23, 2025.

TTK Healthcare Limited Business Segment

The company operates in a single integrated business segment encompassing manufacturing, marketing, and distribution of pharmaceuticals, consumer products, medical devices, foods, and protective devices, serving domestic and international markets.

Product Mix (% of total turnover):

  • Male Contraceptives: 25.78%
  • Food Products: 16.60%
  • Animal Welfare Products: 15.77%
  • Ayurvedic Preparations: 12.50%
  • Medical Devices: 11.25%
  • Home Care Products: 9.32%
  • Cosmetics and Deodorant: 8.73%

Geography:

  • India: 89.34%
  • Exports: 10.66%

TTK Healthcare Limited Key Management

  • T.T. Raghunathan – Executive Chairman
  • S Kalyanaraman – Managing Director & CEO
  • B V K Durga Prasad – President – Finance (CFO)
  • Gowry A Jaishankar – DGM – Legal & Company Secretary
  • S Ranganath Rao – President – Foods Division
  • Brijj Balaji Singh – President – Protective Devices Division
  • Yogesh Yadav – President – Consumer Products Division

Latest Updates on TTK Healthcare Limited

  • Continued operation of five SBUs and undertook technology upgrades including Oracle APEX rollout and digital tool deployments across sales, order tracking, surgery tracking, and expense management integrated with Oracle EBS.
  • Incurred capital expenditure of Rs.14.33 crore including equipment for Protective Devices and Foods divisions.
  • Recorded profit on sale of leasehold land with building at Mahindra World City, Chennai; wrote off finished goods related to male contraceptives following USAID Stop Work Order.
  • Board inducted three new directors and saw retirement of two directors during the year; appointed a new Company Secretary effective June 1, 2024.
  • Paid regulatory fines related to delayed appointment of a Woman Director and filed appeals.
  • Approved the appointment of Cost Auditors for the ensuing year subject to member ratification.
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

The company was incorporated on May 21, 1958, and its shares are listed on BSE and NSE in India.

The five strategic business units are Pharmaceuticals (Animal Welfare), Consumer Products, Medical Devices, Foods, and Protective Devices, covering a diverse range of products including veterinary formulations, medical implants, consumer brands, and male contraceptives.

No. The company does not have any subsidiaries or joint ventures as per its Board report.